Results 181 to 190 of about 163,380 (264)

Antihypertensive drug-related problems in Vietnamese ambulatory care. [PDF]

Sci Rep
Nguyen HH, Vu LAT, Tran MH, Pham HT.
europepmc   +1 more source

Spike detection in the wild: Screening of suspected temporal lobe epilepsy cases using a tailored 2‐channel wearable EEG

Epilepsia Open, EarlyView.
Abstract Objective To clinically validate the contribution of a custom‐built EEG wearable device (waEEG) compared to a full 10–20 electrode array ambulatory EEG (aEEG) for screening epilepsy cases in patients with suspected temporal lobe epilepsy (TLE) but negative routine EEGs. Methods Patients (aged 16–91 years) with clinically suspected TLE who were
Daniel Filipe Borges, Joana Isabel Soares, Daniela Dias, Helena Cordeiro, Alberto Leal   +4 more
wiley   +1 more source

Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study. [PDF]

J Am Heart Assoc
Levitan EB, Zhu A, Bittner V, Brown TM, Farkouh ME, Girguis M, Huang L, Jackson EA, Judd SE, Rhodes S, Safford MM, Strande JL, Wang MJ, Woodward M, Long DL.   +14 more
europepmc   +1 more source

Real world testing and cost‐effectiveness analysis of subcutaneous EEG (REAL‐ASE): Protocol for a prospective multicentre interventional trial

Epilepsia Open, EarlyView.
Abstract Objective Epilepsy is a common condition associated with significant morbidity, mortality, and costs. Poor documentation of seizures is a major challenge in epilepsy care. Objective seizure counting with mobile devices may mitigate this challenge and improve patient management.
Matthew McWilliam, Pedro F. Viana, Eren Dursun, Joe Davies, Joel S. Winston, Jessica Agren, Harutomo Hasegawa, Jonas Duun‐Henriksen, Mark P. Richardson   +8 more
wiley   +1 more source

Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study. [PDF]

Drug Saf
Plasek JM, Amato MG, Salem A, Foer D, Lipsitz S, Jackson GP, Bates DW, Zhou L.   +7 more
europepmc   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

Regional variation in ambulatory care-sensitive hospitalizations for people with type 2 diabetes in Germany: insights from a claims data analysis using the PopGrouper. [PDF]

Res Health Serv Reg
Tsatsaronis C, Kreutzberg A, Klemt M, Kinder K, Busse R, Quentin W, PopGroup consortium.   +6 more
europepmc   +1 more source

When seizure counts are not seizures: Measurement error and its implications for epilepsy management and driving policy

Epilepsia, EarlyView.
Mark J. Cook, Mark P. Richardson, Andreas Schulze‐Bonhage   +2 more
wiley   +1 more source

Ambient technology in epilepsy clinical practice

Epilepsia Open, EarlyView.
Abstract The utilization of large language model‐based artificial intelligence (AI) in the field of neurology has gained attention as a viable tool to enhance and assist providers with processes ranging from scheduling patients to providing preliminary interpretations of testing results, pending orders, and documenting encounters. Epileptologists could
Haania Kakwan, Justin F. Rousseau, Lidia M. Moura, Irfan S. Sheikh   +3 more
wiley   +1 more source

Informed Consent for Ambient Documentation Using Generative AI in Ambulatory Care.

JAMA Netw Open
Lawrence K, Kuram VS, Levine DL, Sharif S, Polet C, Malhotra K, Owens K.   +6 more
europepmc   +1 more source